What is Borba?
Borba operates at the intersection of nutritional science and topical skincare, distinguishing itself through a holistic 'inside-out' methodology. The company specializes in age-defying formulations that utilize potent antioxidants, such as acai-derived anthocyanins, to combat environmental stressors and UV-induced skin damage. By integrating therapeutic-grade ingredients into a comprehensive product suite—ranging from clarifying cleansers to orbital eye rejuvenators—Borba addresses the complex needs of consumers seeking both hydration and oil control. Its market position is defined by a commitment to evidence-based beauty, moving beyond traditional cosmetic applications to offer functional, health-centric skincare solutions that resonate with a sophisticated, wellness-oriented demographic.
How much funding has Borba raised?
Borba has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Borba
PPP
Public-Private Partnership
What's next for Borba?
With the successful closure of this late-stage funding, Borba is poised to execute a multi-faceted growth strategy. The primary focus will likely involve expanding its distribution channels and enhancing its product pipeline to include more advanced, photoprotective formulations. Furthermore, the company is expected to leverage this capital to strengthen its brand equity through targeted marketing campaigns that emphasize the scientific efficacy of its antioxidant-rich product lines. As Borba scales, the strategic deployment of these funds will be instrumental in maintaining its competitive edge, potentially facilitating entry into new international markets and fostering deeper consumer engagement through digital-first wellness platforms. The company's ability to sustain its growth trajectory will depend on its continued innovation in the dermatological space and its capacity to adapt to evolving consumer preferences for clean, high-performance beauty products.
See full Borba company page